ClinicalTrials.gg
RecruitingNCT05956366VIBUS-wp1Updated Apr 3, 2024

Effectiveness of Family-based Intervention for Youn Persons With Eating Disorders

An observational study in Eating Disorders, sponsored by Mental Health Services in the Capital Region, Denmark. Recruiting at 1 site in Denmark. Open to participants aged 7 Years to 17 Years. Per ClinicalTrials.gov, last updated 2024-04-03.

Sponsored by Mental Health Services in the Capital Region, Denmark · Observational

From the registry’s dates

  • Started Apr 2018; still recruiting 8 years 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
7 Years to 17 Years
Sex
All
01

Study summary

This research project aims to characterize a naturalistic cohort of children and adolescents with eating disorders in terms of biological, psychological and psychopathological features. Further, the project will examine the effectiveness of treatment, the determinants of treatment outcome and the course of treatment response for children and adolescents with eating disorders (ED), treated in a generic specialist child and adolescent mental health service. The first choice of treatment is outpatient family-based treatment (FBT), which has documented effect for anorexia nervosa and bulimia nervosa. However, a subgroup of young persons with eating disorders does not respond sufficiently to this treatment, and evidence concerning effective treatment for children and adolescents with atypical eating disorders is still lacking. Further, treatment effectiveness for children and adolescents in a Danish naturalistic setting has never been examined.

Read the detailed description

The overall aim is to assess associations between patient characteristics and treatment response across the spectrum of eating disorders to identify, which patients benefit from family based treatment, and which patients possibly would need other kinds of treatment or more intensive care.

Research questions:

  1. Which patient and family characteristics predict faster recovery from ED in childhood and adolescence?
  2. Which patient and family characteristics predict intensification of treatment in the forms of day hospital or full hospitalization?
  3. At which time point can recovery be predicted based on information from initial assessment and/or assessment during the course of treatment?
  4. Which patient and family characteristics (e.g. patterns of comorbid symptoms) are common in those not responding well to treatment within each diagnostic category?
  5. How many young patients migrate between ED diagnoses, and what characterizes these patients?
  6. Studies on treatment effectiveness for EDNOS in children and adolescents are still lacking. Hence, an important research question of this study is whether family based treatment for EDNOS is effective and is perceived as helpful by patients and families?

    In addition, the project will seek to answer the following:

  7. Is treatment effectiveness in The Capital Region of Denmark (BUC) comparable to published results from other countries in the same age group?
02

Conditions studied

  • Eating Disorders

Keywords

  • eating disorders, adolescents
03

In context

Feeding and Eating Disorders

645 studies on the registry are indexed under Feeding and Eating Disorders; 153 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 102 across 177 observational studies indexed under Feeding and Eating Disorders.

Browse Feeding and Eating Disorders studies →

Lead sponsor

Mental Health Services in the Capital Region, Denmark is the lead sponsor of 49 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients assessed and treated for any eating disorder (ICD-10: F50.0-F50.8) in the unit for treatment of eating disorders will be invited to participate.

Due to the naturalistic design of this study we will examine a representative, consecutive sample, without any exclusion criteria except the absence of informed consent by patient and parents or legal care takers.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • begin treatment for eating disorder

Exclusion criteria

Exclusion Criteria:

  • lack of
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Anorexia nervosa

    Children and adolescents presenting for treatment for anorexia nervosa typica or atypica (ICD-10: F50.0 or F50.1)

    Behavioral: Family-based treatment

  • Bulimia nervosa

    Children and adolescents presenting for treatment for bulimia nervosa typica or atypica (ICD-10: F50.2 or F50.3)

    Behavioral: Family-based treatment

  • Other eating disorders

    Children and adolescents presenting for treatment for other eating disorders (ICD-10: F50.8)

    Behavioral: Family-based treatment

Interventions

  • BehavioralFamily-based treatment

    Open-end family therapy ad modum The Maudsley model

    Also known as: FBT

06

What researchers measure

Primary outcomes

  1. proportion of participants with weight normalisation

    at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory. BMI is calculated as weight in kg/(height in meters\*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents

    Time frame: through treatment completion an average of 1 year

  2. proportion of participants with weight normalisation

    at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory. BMI is calculated as weight in kg/(height in meters\*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents

    Time frame: 2.5 years after treatment completion

  3. proportion of participants with weight normalisation

    at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory. BMI is calculated as weight in kg/(height in meters\*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents

    Time frame: 5 years after treatment completion

  4. proportion of participants with weight normalisation

    at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory. BMI is calculated as weight in kg/(height in meters\*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents

    Time frame: 7.5 years after treatment completion

  5. proportion of participants with weight normalisation

    at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory. BMI is calculated as weight in kg/(height in meters\*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents

    Time frame: 10 years after treatment completion

  6. proportion of participants with absence of eating disordered behaviors

    absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE).

    Time frame: through treatment completion an average of 1 year

  7. proportion of participants with absence of eating disordered behaviors

    absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE).

    Time frame: 2.5 years after treatment completion

  8. proportion of participants with absence of eating disordered behaviors

    absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE).

    Time frame: 5 years after treatment completion

  9. proportion of participants with absence of eating disordered behaviors

    absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE).

    Time frame: 7.5 years after treatment completion

  10. proportion of participants with absence of eating disordered behaviors

    absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE).

    Time frame: 10 years after treatment completion

07

Study locations

1 of 1 sites recruiting
  • Child and Adolescent Mental Health Care Center
    Copenhagen, DK-2400, Denmark
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2018 (actual). Primary completion is estimated for Dec 2035, 212 months after the start.

Of 61 non-industry observational studies under Feeding and Eating Disorders, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 95. This study's planned 212 months is above that.

Counting every sponsor, half of 64 studies reached it within 42 months; a quarter within 18 and three quarters within 95.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2023
First posted
Jul 21, 2023
StartActual
Apr 1, 2018
Primary completionEst.
Dec 31, 2035
CompletionEst.
Dec 31, 2037
Last update
Apr 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05956366
Lead sponsor
Mental Health Services in the Capital Region, Denmark
Responsible party
Sponsor
First posted
Jul 21, 2023
Start date
Apr 1, 2018
Primary completion
Dec 31, 2035 (estimated)
Completion
Dec 31, 2037 (estimated)
Last update
Apr 3, 2024

Study contacts

Mette Bentz, PhD
Contact
mette.bentz@regionh.dk
+45 38 64 10 35
Mette Bentz, PhD
principal investigator · Child and Adolescent Mental Health Care Centre, Capital Region of Denmark
Anne Katrine Pagsberg, professor
study director · Child and Adolescent Mental Health Care Centre, Capital Region of Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion